JAK2 and cancer: Second, further physiological and pathophysiological experiments are required to confirm the correlations between JAK2 mutation and increased cancer immunogenicity and anticancer immunity, such as in vivo and in vitro experiments to explore the role of JAK2 in ICI treatment.